The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 01, 2019

Filed:

Aug. 29, 2017
Applicant:

Microvax, Llc, Warrenton, VA (US);

Inventor:

Albert B. Deisseroth, Potomac, MD (US);

Assignee:

MicroVAX, LLC, Warrenton, VA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 38/17 (2006.01); A61K 39/12 (2006.01); A61K 39/42 (2006.01); C07K 16/28 (2006.01); C12N 15/86 (2006.01); C07K 14/005 (2006.01); A61K 39/00 (2006.01); A61K 39/245 (2006.01);
U.S. Cl.
CPC ...
A61K 39/245 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/57 (2013.01); C12N 2710/10343 (2013.01); C12N 2710/16634 (2013.01);
Abstract

The present invention is directed to novel compositions and methods against HSV (herpes simplex virus) 1 and 2. In brief, an epitope from a binding region of glycoprotein gD, important for binding or attachment of the HSV to the host cell, which is used to mediate the first essential function of infection, and three epitopes from binding regions of glycoprotein gB are used to mediate the second essential function of infection or the fusion of the HSV envelope with the cellular plasma membrane. Each of these epitopes is fused or linked with the extracellular domain of protein CD40L, to form a fusion protein, which fusion proteins are then combined in a mixture to form the inventive composition for acting against HSV 1 and 2.


Find Patent Forward Citations

Loading…